Department of Gastroenterology, Sendai City Medical Center, Japan.
Department of Surgery, Sendai City Medical Center, Japan.
Intern Med. 2022 Apr 1;61(7):935-942. doi: 10.2169/internalmedicine.7889-21. Epub 2021 Sep 11.
Objective The diagnostic accuracy of an endoscopic ultrasound-guided fine-needle aspiration cytology/biopsy combined with a cell-block method (FNA-CB) for gastrointestinal subepithelial lesions (GI-SELs) has not been fully studied. Methods A total of 109 patients (with 110 GI-SELs) were evaluated to clarify the rate of obtaining evaluable histology specimens using FNA-CB. In addition, we investigated the following: 1) the accuracy for determining the histology, 2) effects of the number of cell clusters obtained via FNA-CB, 3) correlation of the Ki67 labelling index (Ki67LI) of the gastrointestinal stromal tumor (GIST) lesions between FNA-CB and resected specimens, and 4) clinical courses for patients followed up after FNA-CB. Results Of the 110 GI-SELs for which FNA-CB was performed, 95 (86%) were able to be histologically evaluated using the first FNA-CB. For the 70 resected GI-SELs, the accuracy of FNA-CB to determine histology was 96%, remaining at 90% even when only a few cell clusters were obtained. The concordance rate of the risk-grouping of GIST (high-risk, Ki67LI ≥8; low-risk, <8) between FNA-CB and resected specimens was 84%. Of the 29 patients followed up after the first FNA-CB, 12 with benign GI-SELs determined using the first FNA-CB showed no obvious increases in their GI-SEL sizes. Conclusion Since FNA-CB can be used to determine the histology and reproductive activity of GI-SELs accurately, not only preoperative histological confirmation but also reliable information to determine clinical plans, such as follow-up without surgery or neoadjuvant chemotherapy, can be obtained.
目的 内镜超声引导下细针抽吸细胞学/活检联合细胞块法(FNA-CB)对胃肠道黏膜下病变(GI-SELs)的诊断准确性尚未得到充分研究。方法 共评估了 109 例(110 个 GI-SELs)患者,以明确 FNA-CB 获得可评估组织学标本的比率。此外,我们还研究了以下内容:1)确定组织学的准确性,2)通过 FNA-CB 获得的细胞簇数量的影响,3)胃肠道间质瘤(GIST)病变的 Ki67 标记指数(Ki67LI)在 FNA-CB 和切除标本之间的相关性,以及 4)FNA-CB 后随访患者的临床过程。结果 在进行 FNA-CB 的 110 个 GI-SELs 中,95(86%)个可通过首次 FNA-CB 进行组织学评估。对于 70 个切除的 GI-SELs,FNA-CB 确定组织学的准确性为 96%,即使仅获得少量细胞簇,其准确性仍保持在 90%。FNA-CB 和切除标本之间 GIST(高危,Ki67LI≥8;低危,<8)风险分层的一致性率为 84%。在首次 FNA-CB 后随访的 29 例患者中,12 例首次 FNA-CB 确定为良性 GI-SELs 的患者,其 GI-SEL 大小无明显增加。结论 由于 FNA-CB 可准确确定 GI-SEL 的组织学和增殖活性,不仅可以获得术前组织学确认,还可以获得可靠的信息来确定临床计划,例如无需手术或新辅助化疗的随访。